We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
215 result(s) found, displaying 11 to 20
-
Prescription medicine registrationActive ingredients: apadamtase alfa, cinaxadamtase alfa.
-
Prescription medicine registrationActive ingredients: Brentuximab vedotin.
-
Prescription medicine registrationActive ingredients: normal immunoglobulin.
-
Australian public assessment report (AusPar)Fruzaqla (fruquintinib) is approved for the treatment of adult patients with metastatic colorectal cancer (mCRC).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FRUZAQLA fruquintinib 1 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FRUZAQLA fruquintinib 5 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Takeda Pharmaceuticals Australia Pty Ltd - Syringe, general-purpose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAKHZYRO lanadelumab 150 mg/1 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: fruquintinib.
-
Cancellation by sponsorRequested by Takeda Pharmaceuticals Australia Pty Ltd